About Elysium Pharmaceuticals Ltd
Data last updated:
Elysium Pharmaceuticals Ltd is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PLC024164. Its GSTIN is 24AABCE1232A1ZN (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹16 Cr. It is led by directors including Yashwantrai Chunibhai Patel (Managing Director) and Jinkal Darshan Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.1175 P.O. Dabhasa Tal. Padra, Vadodara, Gujarat, India – 391440.
As per the financials filed for FY 2024, the company reported a revenue of ₹159.55 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹18.35 Cr (net margin 11.5%) and EBITDA of ₹37.66 Cr (EBITDA margin 23.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
The company has about 337 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Elysium Pharmaceuticals. As per MCA filings, the company has open charges of ₹81.05 Cr and satisfied charges of ₹165.22 Cr on record. Court records list 328 cases involving the company, including 263 filed by the company and 64 filed against it; 90 cases are pending. The company has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elysiumpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.1175 P.O. Dabhasa Tal. Padra, Vadodara, Gujarat, India – 391440
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Elysium Pharmaceuticals Ltd
The main business activity of Elysium Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elysium Pharmaceuticals Ltd FY 2024 filings available
Elysium Pharmaceuticals Ltd reported revenue of ₹159.55 Cr (down 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Elysium Pharmaceuticals Ltd
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elysium Pharmaceuticals Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18.35 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elysium Pharmaceuticals Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elysium Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals Ltd is audited by O. P. RATHI & CO. for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| O. P. RATHI & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals has 7 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vithalbhai Shankerbhai Patel | Director | 21 Jun 2006 | 20 Years 3 Months | Current |
| Hiren Prakash Barot Also directs: Barot & Barot Developers LLP | Additional Director | 17 Feb 2025 | 1 Years 7 Months | Current |
| Jinkal Darshan Patel Also directs: Atlanta Electricals Limited | Whole-Time Director | 30 Jan 2020 | 6 Years 8 Months | Current |
| Chandani Ankitkumar Jhanwar Also directs: Rama Polycon Limited, Ratnadeep Metal and Tubes Limited | Director | 17 Feb 2023 | 3 Years 7 Months | Current |
| Shitalkumar Navnitbhai Patel | Whole-Time Director | 30 Jan 2020 | 6 Years 8 Months | Current |
| Yashwantrai Chunibhai Patel | Managing Director | 25 Sep 2015 | 11 Years 0 Months | Current |
Ownership and Shareholding of Elysium Pharmaceuticals Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elysium Pharmaceuticals Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2022 | Others | ₹18.43 Cr | Open |
| 04 Jul 2014 | Others | ₹31.31 Cr | Open |
| 11 Dec 2010 | Others | ₹31.31 Cr | Open |
| 15 Mar 2022 | Others | ₹2.29 Cr | Satisfied |
| 27 Oct 2021 | Others | ₹26 Cr | Satisfied |
Total charge records: 18 View all charges
Deals & Funding of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals Ltd has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2016 | Rights issue | ₹2 Cr | Investors: an individual |
| Jul 2010 | Funding round | ₹19.7 Lakh | Investors: 4 individuals |
| Apr 2007 | Funding round | ₹1.11 Cr | Investors: Others - Elysium Pharmaceuticals Limited, 3 individuals |
| Aug 2006 | Funding round | ₹4.29 Cr | Investors: Others - Elysium Pharmaceuticals Limited, 3 individuals |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals Ltd has 328 court cases on record: 263 filed by Elysium Pharmaceuticals, 64 filed against it, 1 where it is another party. 90 cases are pending and 238 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 250 | 49 | 32 |
| High courts | 78 | 15 | 58 |
Cases on record (5 of 328)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Mak Polyplast Private Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Mak Ampoules Pvt Ltd | Pending |
| Bombay High Court | Court case (SS) | Filed against the company by Mak Ampoules Pvt Ltd | Disposed |
| Bombay High Court | Court case (SS) | Filed against the company by Mak Polyplast Private Limited | Disposed |
| High Court of Gujarat | Court case (COMP) | Filed against the company by Mak Ampoules Pvt Ltd | Disposed |
Full case history
All 328 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals operates one associated brand: Elysium Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Heavy machinery components including gears and mill equipment are manufactured. | elysiumpharma.com |
Employees and EPFO Compliance at Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals Ltd has a workforce of 337 employees as of Mar 03, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231GJ1995PTC024164. The current CIN is U24231GJ1995PLC024164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231GJ1995PLC024164 | Current |
| U24231GJ1995PTC024164 | Previous |
Recent Activity on Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals Ltd has 17 board changes on record since 2006: 7 appointments and 10 cessations. The latest: Hiren Prakash Barot was appointed as Additional Director on 17 Feb 2025.
52 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Elysium Pharmaceuticals Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elysium Pharmaceuticals Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elysium Pharmaceuticals Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCE1232A1ZN | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elysium Pharmaceuticals Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elysium Pharmaceuticals Ltd
Elysium Pharmaceuticals is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 1995 (31+ years old) and is registered under CIN U24231GJ1995PLC024164.
Elysium Pharmaceuticals reported revenue of ₹159.55 Cr for FY 2024 (down 26% YoY).
Elysium Pharmaceuticals has 7 current directors:
- Yashwantrai Chunibhai Patel - Managing Director
- Jinkal Darshan Patel - Whole-Time Director
- Shitalkumar Navnitbhai Patel - Whole-Time Director
- Suhasini Rajnikant Patel - Whole-Time Director
- Vithalbhai Shankerbhai Patel - Director
- Hiren Prakash Barot - Additional Director
- Chandani Ankitkumar Jhanwar - Director
Elysium Pharmaceuticals reported a net profit of ₹18.35 Cr (net margin 11.5%) and EBITDA of ₹37.66 Cr (EBITDA margin 23.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elysium Pharmaceuticals is -1% over three years and 16% over five years. In the latest year (FY 2024) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elysium Pharmaceuticals is 24AABCE1232A1ZN, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Elysium Pharmaceuticals is U24231GJ1995PLC024164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elysium Pharmaceuticals has 328 court cases on record: 263 filed by the company and 64 filed against it. 90 are pending. Most are in the district courts.
Elysium Pharmaceuticals was incorporated on 11 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Elysium Pharmaceuticals has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹5.6 Cr; the latest was in May 2016.